Roy-Proulx G, Meunier M C, Lanteigne A M, Brochu S, Perreault C
Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.
Eur J Immunol. 2001 Aug;31(8):2284-92. doi: 10.1002/1521-4141(200108)31:8<2284::aid-immu2284>3.0.co;2-e.
The presence of dominant epitopes suppresses generation of CTL activity toward other non-dominant epitopes found on the same antigen-presenting cell (APC). This phenomenon, termed immunodomination, drastically restricts the diversity of the repertoire of CTL responses. Under various experimental conditions we assessed the in vivo expansion by tetramer staining and function by expression of O-glycans and intracellular perforin of CTL specific for a dominant (B6(dom1)) and a non-dominant (HY) H2D(b)-restricted epitope. Immunodomination abrogated expansion rather than differentiation of HY-specific CTL. When immunodomination was precluded because HY was presented alone or because high numbers of antigen-bearing APC were present, the numbers of HY-specific T cells detected after antigen priming were similar to those of B6(dom1)-specific T cells. The main difference between T cells that recognized B6(dom1) versus HY was functional rather than quantitative. The key feature of T cells specific for B6(dom1) is that they show striking up-regulation of molecules involved in CTL effector activity rather than accumulating to particularly high levels, as assessed by tetramer staining. These results support the emerging concept that following antigen priming, CTL populations of similar size can display important differences in effector function, and suggest that these functional differences are instrumental in shaping the repertoire of CTL responses.
优势表位的存在会抑制针对同一抗原呈递细胞(APC)上其他非优势表位的CTL活性的产生。这种现象被称为免疫显性,它极大地限制了CTL反应库的多样性。在各种实验条件下,我们通过四聚体染色评估了体内扩增情况,并通过O-聚糖的表达和CTL特异性针对优势(B6(dom1))和非优势(HY)H2D(b)限制性表位的细胞内穿孔素的表达来评估其功能。免疫显性消除了HY特异性CTL的扩增而非分化。当由于单独呈现HY或由于存在大量携带抗原的APC而排除免疫显性时,抗原激发后检测到的HY特异性T细胞数量与B6(dom1)特异性T细胞数量相似。识别B6(dom1)与HY的T细胞之间的主要差异在于功能而非数量。B6(dom1)特异性T细胞的关键特征是,通过四聚体染色评估,它们显示出参与CTL效应活性的分子显著上调,而不是积累到特别高的水平。这些结果支持了一个新出现的概念,即抗原激发后,大小相似的CTL群体在效应功能上可能存在重要差异,并表明这些功能差异有助于塑造CTL反应库。